Keyword: Insys Therapeutics
With federal prosecutors laying waste to Insys' executive team, one big domino was still left to fall: Founder and former CEO John Kapoor.
With two more former Insys executives facing prison time, another is claiming sexist hiring as an excuse for her role in a kickback scheme.
Another Insys exec faces prison time for an elaborate scheme to pay doctors in return for stepped-up prescriptions for fentanyl spray Subsys.
A federal judge said prosecutors failed to present enough evidence to charge Insys founder John Kapoor on conspiracy in the drugmaker's Subsys sales.
As Insys reaches the last days of its bankruptcy liquidation, it's offering to settle its opioid overhang at pennies on the dollar for plaintiffs.
Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.
Hikma says it has picked up some pipeline products and nasal and sublingual spray equipment from Insys Therapeutics' bankruptcy.
When Insys settled with the feds for $225 million, the drugmaker hoped it had put its troubled past behind it. Now they’re filing for bankruptcy.
After federal prosecutors bagged multiple former execs, Insys had to know its day of reckoning was near. Now it's here—and it'll cost $225 million.